150 related articles for article (PubMed ID: 15923690)
1. Meropenem.
Shah D; Narang M
Indian Pediatr; 2005 May; 42(5):443-50. PubMed ID: 15923690
[TBL] [Abstract][Full Text] [Related]
2. Meropenem use and colonization by antibiotic-resistant Gram-negative bacilli in a pediatric intensive care unit.
Toltzis P; Dul M; O'Riordan MA; Melnick D; Lo M; Blumer J
Pediatr Crit Care Med; 2009 Jan; 10(1):49-54. PubMed ID: 19057450
[TBL] [Abstract][Full Text] [Related]
3. Empiric monotherapy in neutropenia: a realistic goal?
Del Favero A; Bucaneve G; Menichetti F
Scand J Infect Dis Suppl; 1995; 96():34-7. PubMed ID: 7652501
[TBL] [Abstract][Full Text] [Related]
4. Meropenem, a new carbapenem antibiotic.
Fish DN; Singletary TJ
Pharmacotherapy; 1997; 17(4):644-69. PubMed ID: 9250544
[TBL] [Abstract][Full Text] [Related]
5. Update on the efficacy and tolerability of meropenem in the treatment of serious bacterial infections.
Mohr JF
Clin Infect Dis; 2008 Sep; 47 Suppl 1():S41-51. PubMed ID: 18713049
[TBL] [Abstract][Full Text] [Related]
6. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N
Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).
Rhomberg PR; Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2006 Sep; 56(1):57-62. PubMed ID: 16631338
[TBL] [Abstract][Full Text] [Related]
8. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
Matthews SJ; Lancaster JW
Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
[TBL] [Abstract][Full Text] [Related]
9. An overview of the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program: 1997-2004.
Jones RN; Mendes C; Turner PJ; Masterton R
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):247-56. PubMed ID: 16360548
[TBL] [Abstract][Full Text] [Related]
10. Empirical monotherapy with meropenem in serious bacterial infections in children.
Hsu HL; Lu CY; Tseng HY; Lee PI; Lai HP; Lin WC; Hsieh YC; Lee CY; Huang LM
J Microbiol Immunol Infect; 2001 Dec; 34(4):275-80. PubMed ID: 11825008
[TBL] [Abstract][Full Text] [Related]
11. High activity of meropenem against Gram-negative bacteria from a paediatric Intensive Care Unit, 2001-2005.
Patzer JA; Dzierzanowska D; Pawińska A; Turner PJ
Int J Antimicrob Agents; 2007 Mar; 29(3):285-8. PubMed ID: 17257814
[TBL] [Abstract][Full Text] [Related]
12. Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance.
Jones RN; Kirby JT; Rhomberg PR
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):203-13. PubMed ID: 18329835
[TBL] [Abstract][Full Text] [Related]
13. Meropenem: a review of its use in patients in intensive care.
Hurst M; Lamb HM
Drugs; 2000 Mar; 59(3):653-80. PubMed ID: 10776838
[TBL] [Abstract][Full Text] [Related]
14. Meropenem in the treatment of febrile neutropenic children.
Müller J; Garami M; Constantin T; Schmidt M; Fekete G; Kovács G
Pediatr Hematol Oncol; 2005 Jun; 22(4):277-84. PubMed ID: 16020114
[TBL] [Abstract][Full Text] [Related]
15. Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005).
Rhomberg PR; Jones RN
Diagn Microbiol Infect Dis; 2007 Feb; 57(2):207-15. PubMed ID: 16949243
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
[TBL] [Abstract][Full Text] [Related]
17. Carbapenems: a potent class of antibiotics.
Nicolau DP
Expert Opin Pharmacother; 2008 Jan; 9(1):23-37. PubMed ID: 18076336
[TBL] [Abstract][Full Text] [Related]
18. Meropenem pharmacokinetics in children and adolescents receiving hemodialysis.
Goldstein SL; Murry DJ; May S; Aleksic A; Sowinski KM; Blaney S
Pediatr Nephrol; 2001 Dec; 16(12):1015-8. PubMed ID: 11793091
[TBL] [Abstract][Full Text] [Related]
19. Parenteral carbapenems.
Shah PM
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():175-80. PubMed ID: 18154543
[TBL] [Abstract][Full Text] [Related]
20. Use of meropenem in the treatment of serious infections in children: review of the current literature.
Arrieta A
Clin Infect Dis; 1997 Feb; 24 Suppl 2():S207-12. PubMed ID: 9126695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
